Pharma-Bio Serv (PBSV) Invested Capital (2016 - 2025)
Historic Invested Capital for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $11.9 million.
- Pharma-Bio Serv's Invested Capital fell 1313.19% to $11.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $11.9 million, marking a year-over-year decrease of 1313.19%. This contributed to the annual value of $11.9 million for FY2025, which is 1313.19% down from last year.
- As of Q4 2025, Pharma-Bio Serv's Invested Capital stood at $11.9 million, which was down 1313.19% from $11.9 million recorded in Q3 2025.
- Pharma-Bio Serv's Invested Capital's 5-year high stood at $23.8 million during Q3 2021, with a 5-year trough of $11.9 million in Q4 2025.
- In the last 5 years, Pharma-Bio Serv's Invested Capital had a median value of $16.0 million in 2022 and averaged $16.1 million.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 685.16% in 2021, then crashed by 3226.47% in 2022.
- Over the past 5 years, Pharma-Bio Serv's Invested Capital (Quarter) stood at $18.9 million in 2021, then fell by 12.46% to $16.6 million in 2022, then dropped by 2.6% to $16.1 million in 2023, then fell by 14.95% to $13.7 million in 2024, then fell by 13.13% to $11.9 million in 2025.
- Its last three reported values are $11.9 million in Q4 2025, $11.9 million for Q3 2025, and $12.1 million during Q2 2025.